Is the Wolverine Stack Banned? WADA Status of BPC-157 and TB-500

In this article
Short answer: If you are a tested athlete, the Wolverine stack is off the table. BPC-157 is explicitly named on WADA's Prohibited List under category S0, Non-Approved Substances, and TB-500 is named under S2 as part of Thymosin-β4 and its derivatives. Both are prohibited at all times, in and out of competition.
The "Wolverine stack" — the nickname for pairing BPC-157 with TB-500 — is all over forums framed as a recovery protocol, and the appeal is easy to understand: two of the most-discussed recovery peptides, one combination. What that content almost never leads with is the one fact that matters most to a meaningful slice of readers: for tested athletes, this combination can end a season or a career. This article gives you the status plainly, with dates and sources, so you can make the call with full information. For non-sport questions, our safety and sourcing guide has you covered; our Wolverine stack overview covers what the combination is claimed to be.
What WADA's Prohibited List actually says
WADA publishes a new Prohibited List every January 1. Two categories carry the Wolverine stack:
- BPC-157 — S0 Non-Approved Substances. BPC-157 has been explicitly named on the Prohibited List since January 1, 2022 (before that it was covered only by the S0 catch-all for unapproved pharmacological substances). USADA states it directly: "BPC-157 is prohibited under the S0 Non-Approved Substances category of the List." Prohibited at all times, in- and out-of-competition. Not a gray area — a named substance
[regulatory record — WADA/USADA]. - TB-500 — S2 Peptide Hormones, Growth Factors, Related Substances, and Mimetics. TB-500 is separately named under S2 as part of the Thymosin-β4 and-derivatives entry — the growth-factor family of the list. Same "at all times" prohibition
[regulatory record — WADA Prohibited List].
"At all times" deserves emphasis: these aren't competition-day substances like stimulants. There is no window where a tested athlete can use them.
What "banned" means in practice
For a tested athlete, an adverse analytical finding triggers the standard anti-doping consequences: provisional suspension, potential multi-year ineligibility, loss of results, medals, rankings, and — for professionals — contracts and sponsorships. Collegiate athletes and Olympic-movement athletes live under the same practical reality.
Three points the forums skip:
- "Not approved anywhere" is the core issue. Neither compound has completed human approval with the FDA or any comparable authority — which is what places them in their respective categories. Per McGuire et al.'s 2025 scoping review (PMC12446177), the entire human evidence base for BPC-157 is three small pilot studies.
- Detection is real and improving. Anti-doping laboratories screen for peptide drugs routinely, and an explicitly named substance is a named target. Assuming a compound is "undetectable" is a gamble with your eligibility.
- The regulatory direction is toward clarity, not loopholes. In July 2026, the FDA's Pharmacy Compounding Advisory Committee recommended BPC-157 and TB-500 for the 503A compounding Bulks List (advisory, non-binding — rulemaking realistically 2027 or later). Even if that opens a lawful US compounding lane, it would not change WADA status. Pharmacy law and anti-doping rules are separate systems; a prescription would not be permission.
Who this does and doesn't apply to
Anti-doping rules bind athletes in tested pools — Olympic-movement sports, professional leagues with WADA-aligned programs, collegiate athletics, tested strength and physique federations. If that's you, this article is your answer, and the answer is no.
If you're not a tested athlete, WADA's list doesn't bind you. It's still useful information — S0/S2 status tells you no regulator has established these compounds as safe and effective for human use — but it doesn't dictate your personal choice. That's a decision for you and a licensed provider.
Where the stack lives in the catalog
One practical note for non-tested readers exploring the category: TB-500 isn't sold as a standalone product anywhere in the InstaMed line — it exists only as one of four actives inside KLOW (BPC-157 500 mcg + TB-500 300 mcg + GHK-Cu 3 mg + KPV 500 mcg per strip), which is the blend's home in the catalog. KLOW is available at open checkout. [brand product data]
A word of honest context
Nothing in this article helps sell anything, and it's written that way deliberately: the honest position is that tested athletes should not use these compounds, full stop — including in the strip format sold by brands we resell. We'd rather lose that reader's order than have someone learn about S0 from an anti-doping charge. And one more sourcing fact worth sitting with, whoever you are: a 2026 preprint by Mendias & Awan (not yet peer-reviewed) found 41.6%–71.1% of direct-to-consumer research-peptide samples failing basic quality checks — meaning a gray-market product may not even be what its label claims, which for a tested athlete is a violation risk on top of a violation risk.
The bottom line
For tested athletes, the Wolverine stack is prohibited — BPC-157 named under S0 since 2022, TB-500 named under S2, both at all times, and no TUE pathway realistically exists. For everyone else, WADA status doesn't bind you, but the unapproved-substance reality it encodes is worth weighing with your clinician. And if you explore the category, do it through documented products from the regulated lane — never through gray-market vials whose contents fail testing nearly half the time or more.
If you are not in a tested sport, the same pairing exists needle-free inside KLOW sublingual strips, and everything above still applies to anyone who is tested.
---
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.
Reviewed by counsel against FDA structure/function guidance.
Wolverine stack WADA — quick answers
Is BPC-157 banned by WADA?
Yes. BPC-157 is explicitly named on the WADA Prohibited List under category S0 (Non-Approved Substances), on the list since January 1, 2022, prohibited at all times in and out of competition for tested athletes. USADA confirms this directly.
Is TB-500 banned by WADA?
Yes. TB-500 is named under category S2 (Peptide Hormones, Growth Factors, Related Substances, and Mimetics) as part of the Thymosin-β4 and-derivatives entry — prohibited at all times. Verify the current-year list language before relying on any summary; the list updates every January 1.
Could I get a therapeutic-use exemption (TUE) for BPC-157?
No realistic pathway exists. TUEs are granted for approved medications meeting strict criteria; S0 non-approved substances sit outside that framework.
Would it become legal for athletes if the FDA allows compounding in 2027?
No. Pharmacy compounding law and anti-doping rules are independent systems. Even lawful, prescription-compounded peptides would remain prohibited under WADA rules unless WADA itself changes the list.
Educational content. This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.
FDA disclosure. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The honest peptide brief
One email a month: new research on the compounds we cover, new lots and COAs, and zero hype. Unsubscribe anytime.
We never sell your address. 18+ only.


